General Electric Sells Biopharma Unit for $21 Billion | | 2news.com
Danaher buying GE Life Sciences biopharma business for $21.4 billion
Danaher absorbing GE's bioprocess biz in $21.4bn deal - BioProcess InternationalBioProcess International
General Electric selling Danaher Corporation, its biopharma business
GE Deal With Danaher Shows Culp Is All About the Balance Sheet - Bloomberg
How to Trade GE Stock After Earnings Surge - TheStreet
GE Healthcare leaves GE, looks to 'next chapter'
GE sells biopharma unit for $21 billion | The Seattle Times
GE sells jet-leasing unit to AerCap for $30 bn
GE sells biopharma unit for US$21 billion | CTV News
GE To Sell Its BioPharma Unit For $21.4 Billion To Danaher | GE News
Danaher Selling Off Some Businesses to Sartorius for $750M, Tying the Deal to GE Biopharma Acquisition
GE to Sell Its Biotech Business to Danaher for $21 Billion - WSJ
GE sells BioPharma business to CEO's former company
GE sells biopharma drug business to Danaher for $21.4 bn, Energy News, ET EnergyWorld
GE Sells Coveted $21 Billion BioPharma to Pay Down Crippling Debt Load
Danaher Corporation: General Electric to Sell Biopharma Unit for $21.4 Billion
GE sells BioPharma business to CEO's former company for $21.4 billion | CNN Business
GE to sell BioPharma business to Danaher for $21.4B | Fox Business
Danaher Corporation: General Electric to Sell Biopharma Unit for $21.4 Billion
GE agrees to sell BioPharma unit to Danaher for US$21.4 billion
GE sells biopharma drug business to Danaher for $21.4 billion
GE sells BioPharma business to CEO's former company for $21.4 billion | CNN Business
GE To Sell Biopharma Business For $21.4bn – Independent Newspaper Nigeria
GE Healthcare float sunk in favour of Danaher deal | Evaluate
GE chief Larry Culp sells biopharma business for $21 billion
Baxter sells Biopharma Solutions unit for $4.25B | BioWorld
GE To Sell Its BioPharma Unit For $21.4 Billion To Danaher | GE News
